Illumina, Inc. is an American company that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Using its technologies, the Company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies.

Type
Public
HQ
San Diego, US
Founded
1998
Size (employees)
6,200 (est)+13%
Illumina was founded in 1998 and is headquartered in San Diego, US
Report incorrect company information

Illumina Office Locations

Illumina has offices in Singapore, San Diego, Madison, San Francisco and in 11 other locations
San Diego, US (HQ)
5200 Illumina Way
Madison, US
200 5602 Research Park Blvd
Redwood City, US
800 Saginaw Dr
San Francisco, US
210 499 Illinois St
Santa Clara, US
210 451 El Camino Real
Scoresby, AU
1 International Ct
Show all (15)
Report incorrect company information

Illumina Financials and Metrics

Illumina Revenue

Illumina's revenue was reported to be $2.40 b in FY, 2017
USD

Revenue (Q1, 2019)

782 m

Gross profit (Q1, 2019)

538 m

Gross profit margin (Q1, 2019), %

68.8%

Net income (Q1, 2019)

197 m

EBIT (Q1, 2019)

218 m

Market capitalization (20-Jul-2018)

45.7 b

Closing stock price (20-Jul-2018)

311.2

Cash (1-Apr-2018)

1.6 b

EV

44.9 b
Illumina's current market capitalization is $45.7 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.4 b1.9 b2.2 b2.4 b2.4 b

Revenue growth, %

31%19%8%

Cost of goods sold

670.5 m731.9 m731.9 m

Gross profit

1.5 b1.7 b1.7 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017Q1, 2019

Revenue

356.8 m420.8 m447.6 m480.6 m538.6 m539.4 m550.3 m607.1 m571.8 m600.1 m714 m598 m662 m782 m

Cost of goods sold

146.9 m142.5 m147 m146.7 m163.5 m163 m162.7 m181 m174.7 m176.3 m232 m230 m228 m244 m

Gross profit

209.9 m278.3 m300.5 m333.9 m375 m376.4 m387.5 m426.2 m397.1 m423.8 m482 m368 m434 m538 m

Gross profit Margin, %

59%66%67%69%70%70%70%70%69%71%68%62%66%69%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

711.6 m636.2 m768.8 m734.5 m734.5 m

Accounts Receivable

238.9 m289.5 m385.5 m381.3 m381.3 m

Inventories

22.8 m29.8 m54.3 m77.9 m300.2 m

Current Assets

1.6 b1.9 b2.1 b2.3 b2.3 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017Q1, 2017Q2, 2017Q1, 2019

Cash

691.8 m518.5 m675.2 m829.9 m533.5 m591.1 m551.5 m794.7 m754.9 m951.7 m1.4 b981 m1.2 b1.6 b

Accounts Receivable

235.4 m293 m258.7 m276.7 m350 m368.6 m413.5 m381.6 m402.5 m372.5 m383 m368 m372 m400 m

Inventories

159.9 m164.2 m177.5 m199.3 m205.2 m223.6 m233.8 m312.2 m287.9 m311.4 m327 m299 m309 m350 m

Current Assets

1.5 b1.6 b1.6 b1.9 b2.1 b2.2 b2.2 b2.3 b2.1 b2.1 b2.8 b2.5 b2.6 b3.2 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

125.3 m353.4 m457.4 m428.1 m428.1 m

Depreciation and Amortization

50.8 m61.9 m72.7 m90 m90 m

Inventories

1.8 m6.6 m(11 m)(1.2 m)(29.7 m)

Accounts Payable

2.4 m(2.1 m)46.3 m(2 m)(2 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q3, 2016Q1, 2016Q2, 2016Q1, 2017Q1, 2019

Net Income

31.4 m60 m46.6 m93.5 m136.7 m102.2 m115.6 m116.9 m87.2 m116.4 m348 m197 m

Depreciation and Amortization

30 m

Inventories

177.5 m199.3 m205.2 m223.6 m233.8 m312.2 m287.9 m311.4 m299 m(17 m)

Accounts Payable

91.5 m96.1 m106.7 m107.9 m123.4 m134.1 m154.7 m250.7 m142 m2 m
USDY, 2018

EV/EBIT

205.9 x

EV/CFO

176 x

Financial Leverage

1.8 x
Show all financial metrics
Report incorrect company information

Illumina Online and Social Media Presence

Embed Graph
Report incorrect company information

Illumina News and Updates

Synthetic Biology Global Market 2018: Key Players – Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc.

Synthetic Biology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

DNA Library Preparation Kits Market to Gain a Stronghold by 2025

Region - North America, Latin America, Europe, Asia Pacific & Japan, The Middle East and Africa; Posted via Industry Today. Follow us on Twitter @IndustryToday

Immune Repertoire Sequencing Market Will Reflect Significant Growth Prospects during 2017-2025

Persistence Market Research has announced the addition of the “Immune Repertoire Sequencing Market: Global Industry Analysis and Opportunity Assessment, 2017-2025 "report to their offering Posted via Industry Today. Follow us on Twitter @IndustryToday

Fosmid Cloning Market : Comprehensive Analysis of World Markets & Trade, 2025

Region - North America, Latin America, Europe, Asia Pacific, Middle East & Africa; Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

Illumina Company Life and Culture

Report incorrect company information